Session Details
[O-37]Oral Session 37 Neuroimmunology 4 （Clinical study）
Fri. May 23, 2025 10:15 AM - 11:45 AM JST
Fri. May 23, 2025 1:15 AM - 2:45 AM UTC
Fri. May 23, 2025 1:15 AM - 2:45 AM UTC
第14会場(リーガロイヤルホテル大阪3F 光琳の間②)
Chair: Takahiro Iizuka（Department of Neurology Kitasatouniversity School of Medicine, Japan）
[O-37-1]Clinical features and current status of acute treatment in cryptogenic NORSE in Japan
Tomomi Iwami1, Naomi Kanazawa1, Naomi Nagata1, Shintaro Saegusa1, Shunya Fujiwara1, Masaki Iizuka1, Toshiyuki Nagai1, Makoto Nagashima1, Juntaro Kaneko1, Yuya Onozawa2, Eiji Kitamura1, Taira Toki3, Yutaka Nonoda3, Kazutoshi Nishiyama1, Takahiro Iizuka1 (1.Department of Neurology, Kitasato University School of Medicine, Japan, 2.Laboratory of Physiology, School of Life and Environmental Science, Azabu University, Japan, 3.Department of Pediatrics, Kitasato University School of Medicine, Japan)
[O-37-2]Clinical features of anti-NMDA receptor encephalitis in a Japanese Nationwide Survey (2nd survey)
Izumi Kawachi1, Etsuji Saji1, Yasunori Sato2, Takahiro Iizuka3, Akio Kimura4, Hiroshi Sakuma5, Hideto Nakajima6, Mariko Oishi7, Akihiro Nakajima1, Takashi Kanda7, Yukitoshi Takahashi8, Osamu Watanabe9, Akiyuki Uzawa10, Satoshi Kuwabara10, Osamu Onodera1 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Department of Biostatistics, Keio University School of Medicine, Japan, 3.Department of Neurology, Kitasato University, Japan, 4.Department of Neurology, Gifu University, Japan, 5.Department of Brain and Neural Science, Tokyo Metropolitan Institute of Medical Science, Japan, 6.Division of Neurology, Department of Medicine, Nihon University School of Medicine, Japan, 7.Department of Neurology and Clinical Neuroscience, Yamaguchi University School of Medicine, Japan, 8.Department of Pediatrics, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan, 9.Division of Neurology and Stroke, Kagoshima City Hospital, Japan, 10.Department of Neurology, Graduate School of Medicine, Chiba University, Japan)
Izumi Kawachi, M.D., Ph.D. is presently an Associate Professor in Department of Neurology, Brain Research Institute, Niigata University, and Medical Education Center, Niigata University School of Medicine, Niigata, Japan. She is a director of the Japanese Society for Neuroimmunology, and a councilor of the Japanese Society for Neuropathology, the Japanese Society of Neurology and the Japanese Society of Neurological Therapeutics, as well as serving as a Member of the MS/NMOSD Guidelines Committee 2017 and 2023. Dr. Kawachi graduated from Niigata University in 1993 (MD) and earned her PhD from Niigata University in 2002. Dr. Kawachi undertook training in neurology at Brain Research Institute, Niigata University and then engaged in research of innate immunology as a research associate in Prof. Marco Colonna’s lab, Department of Pathology and Immunology, Washington University, School of Medicine, St. Louis, USA. Her principal research activity has been in MS/NMO/autoimmune encephalitis.
[O-37-3]Evaluation of the usefulness of the Autoimmune Encephalitis Prediction Score in new-onset Epilepsy
Takuma Sato, Mikito Shimizu, Taku Hoshi, Hiroyuki Sumikura, Isao Fukasaka, Kyoko Higashida, Yuki Shimada, Mai Ito, Takahiro Tomoda, Manabu Sakaguchi (Osaka General Medical Center Neurology, Japan)
[O-37-4]Clinical features of anti-mGluR1 encephalitis in Japan
Nobuaki Yoshikura1, Akio Kimura1, Akira Takekoshi1, Keizo Yasui2, Shoko Yamashita3, Kento Skashita4, Naonobu Futamura4, Reiji Koide5, Yuki Kobayashi6, Kazuki Yamada7, Takahiro Maku8, Takayoshi Shimohata1 (1.Department of Neurology Gifu University graduate school of medicine, Japan, 2.Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Japan, 3.Kindai University Hospital, Japan, 4.NHO Hyogo-Chuo National Hospital, Japan, 5.Jichi Medical University Hospital, Japan, 6.Institute of Science Tokyo Hospital, Japan, 7.Hakodate Municipal Hospital, Japan, 8.Fuji City General Hospital, Japan)
[O-37-5]Biomarker of cerebrospinal fluid of autoimmune glial fibrillary acidic protein astrocytopathy
Akio Kimura1, Youichi Maekawa2, Keiko Tanaka3, Yoshihisa Yamano4, Kuniaki Saito5, Yasuko Yamamoto5, Masao Takemura5, Takayoshi Shimohata1 (1.Department of Neurology, Gifu University Graduate School of Medecine, Japan, 2.Department of Parasitology and Infectious Diseases, Gifu University Graduate School of Medicine, Japan, 3.Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 4.Department of Neurology, St. Marianna University School of Medicine, Japan, 5.Faculty of medical technology, Fujita Medical University, Japan)
[O-37-6]Clinical significance of CSF antibody titers based on HIS score in anti-NMDA receptor encephalitis
Masaki Iizuka, Naomi Kanazawa, Naomi Nagta, Hitomi Nakagawa, Tomomi Iwami, Shintaro Saegusa, Masaaki Nakamura, Juntaro Kaneko, Eiji Kitamura, Kazutoshi Nishiyama, Takahiro Iizuka (Department of Neurology, Kitasato University School of Medicine, Japan)